Awakn Life Sciences (FRA:954) ROC % : -797.47% (As of Oct. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Awakn Life Sciences's annualized return on capital (ROC %) for the quarter that ended in Oct. 2024 was -797.47%.

As of today (2025-03-14), Awakn Life Sciences's WACC % is 18.77%. Awakn Life Sciences's ROC % is -1852.99% (calculated using TTM income statement data). Awakn Life Sciences earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Awakn Life Sciences ROC % Historical Data

The historical data trend for Awakn Life Sciences's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences ROC % Chart

Awakn Life Sciences Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

ROC %

-174.25

-345.63

-113.45

-196.42

Awakn Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
ROC %	Get a 7-Day Free Trial											-3,484.11	-5,236.36	-3,912.33	-1,241.27	-797.47

Awakn Life Sciences ROC % Calculation

Awakn Life Sciences's annualized Return on Capital (ROC %) for the fiscal year that ended in Jan. 2024 is calculated as:

	ROC % (A: Jan. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Jan. 2023 )	+	Invested Capital (A: Jan. 2024 ))	/ count )
=	-2.685 * ( 1 - 0% )	/	( (2.697	+	0.037)	/ 2 )
=	-2.685	/	1.367
=	-196.42 %

where

	Invested Capital		(A: Jan. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3.038	-	1.37	-	( 0.381	-	max(0, 1.703	-	0.674	+	0.381	))
=	2.697

	Invested Capital		(A: Jan. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.371	-	1.413	-	( 0.278	-	max(0, 1.418	-	0.339	+	0.278	))
=	0.037

Awakn Life Sciences's annualized Return on Capital (ROC %) for the quarter that ended in Oct. 2024 is calculated as:

	ROC % (Q: Oct. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jul. 2024 )	+	Invested Capital (Q: Oct. 2024 ))	/ count )
=	-1.26 * ( 1 - 0% )	/	( (0.216	+	0.1)	/ 2 )
=	-1.26	/	0.158
=	-797.47 %

where

	Invested Capital		(Q: Jul. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.604	-	1.464	-	( 0.479	-	max(0, 1.655	-	0.579	+	0.479	))
=	0.216

	Invested Capital		(Q: Oct. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.446	-	1.385	-	( 0.338	-	max(0, 1.463	-	0.424	+	0.338	))
=	0.1

Note: The Operating Income data used here is four times the quarterly (Oct. 2024) data.

Awakn Life Sciences (FRA:954) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Awakn Life Sciences's WACC % is 18.77%. Awakn Life Sciences's ROC % is -1852.99% (calculated using TTM income statement data). Awakn Life Sciences earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Awakn Life Sciences ROC % Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (FRA:954) » Definitions » ROC %

Comparable Companies

Traded in Other Exchanges

N/A

Address

301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2

Website

https://www.awaknlifesciences.com

Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences Headlines

No Headlines